IR-event
BRAIN Capital Market Day
Meet BRAIN on September 15, 2020 in Zwingenberg.
Investors
BRAIN is a key player in the bio-based economy
BRAIN AG ranks among the technologically leading companies in Europe in the bioeconomy area, and operates in industrial – so-called white – biotechnology with its key technologies.
BRAIN identifies previously untapped high-performing enzymes, microbial producer organisms and natural compounds derived from complex biological systems to transform them into industrially usable applications.
Innovative solutions and products developed from this Toolbox of Nature are successfully deployed in the chemicals sector, as well as in the cosmetics and food manufacturing industries.
As part of its growth-oriented industrialization strategy, B.R.A.I.N. Biotechnology Research and Information Network AG (BRAIN AG; ISIN DE0005203947 / WKN 520394) has been the first bioeconomy company to be listed in the Prime Standard of the Frankfurt Stock Exchange since February 2016.
Selected publications and financial events
Good reasons to invest in BRAIN
-
Megatrend
trailblazer -
High-tech
disruptor -
Diverse range
of applications -
Reliable
partner -
Global
provider
Megatrend
trailblazer
BRAIN is widely recognized as a trailblazer for the transformation of a mineral oil-based economy towards sustainable industrial production based on industrial biotechnology. The fast-growing bioeconomy is a megatrend of the 21st century.
High-tech
disruptor
BRAIN applies a world-class biotechnology portfolio to its proprietary BioArchive. Research and development acitivties are driven by a solution-focused mindset which overcomes the limitations of the single technology approach that other players in the field of biotechnology are confronted with.
Diverse range
of applications
Based on nature’s biodiversity BRAIN focuses on three product categories only, but they cover highly differing industrial applications ranging from healthier food to sustainable green mining without depending on any single market.
Reliable
partner
BRAIN supports its customers in their endeavors to differentiate themselves from competitors, understanding that the key to successful business is the right partnership model. BRAIN looks back on more than 100 successful joint R&D projects with major international companies.
Global
provider
BRAIN Group companies are leaders in their fields and unite first-class R&D, production expertise and access to attractive markets under one roof. All BRAIN Group companies act as interconnected entities addressing specific B2B markets and industrial partners.
Investor Relations service
You want to invest in BRAIN or have questions? We are here for you. Please get in touch with us.
